Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet-derived mitochondria transplantation for myocardial ischemia
IRCT20210920052524N1Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Oct 2021
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of platelet-derived mitochondria in cardiac ischemia (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Cardiac arrhythmia, Non-fatal myocardial infarction and 6 more. Started Oct 2021; status: completed.
02
Drugs
platelet-derived mitochondria
03
Conditions
cardiac ischemia
Beyond the preview
Go deeper on IRCT20210920052524N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210920052524N1.